Fabio Rocha Formiga

Dr. Fabio Rocha Formiga

Oswaldo Cruz Foundation (FIOCRUZ)/Aggeu Magalhães Institute (IAM), and University of Pernambuco (UPE), Recife PE 50740-590, Brazil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Journal of Controlled Release
Verified
Journal Article
Closed access
Fabio Rocha FormigaFabio Rocha Formiga
Fabio Rocha Formiga
BPBeatriz Pelacho
Beatriz Pelacho
Elisa Garbayo AtienzaElisa Garbayo Atienza
Elisa Garbayo Atienza
GAGloria Abizanda
Gloria Abizanda
JGJuan J Gavira
Juan J Gavira
María J. Blanco PrietoMaría J. Blanco Prieto
María J. Blanco Prieto

1 January 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
Fabio Rocha FormigaFabio Rocha Formiga
Fabio Rocha Formiga
BPBeatriz Pelacho
Beatriz Pelacho
Elisa Garbayo AtienzaElisa Garbayo Atienza
Elisa Garbayo Atienza
IIIzaskun Imbuluzqueta
Izaskun Imbuluzqueta
PDPaula Díaz-Herráez
Paula Díaz-Herráez
María J. Blanco PrietoMaría J. Blanco Prieto
María J. Blanco Prieto

1 January 2012 in Theranostics
Verified
Journal Article
Open access
TSTeresa Simón-Yarza
Teresa Simón-Yarza
Fabio Rocha FormigaFabio Rocha Formiga
Fabio Rocha Formiga
ETEsther Tamayo
Esther Tamayo
BPBeatriz Pelacho
Beatriz Pelacho
FPFelipe Prosper
Felipe Prosper
María J. Blanco PrietoMaría J. Blanco Prieto
María J. Blanco Prieto
Since the discovery of the Vascular Endothelial Growth Factor (VEGF) and its leading role in the angiogenic process, this has been seen as a promising molecule for promoting neovascularization in the infarcted heart. However, even though several clinical trials were initiated, no therapeutic effects were observed, due in part to the short half life of this factor when administered directly to the tissue. In this context, drug delivery systems appear to offer a promising strategy to overcome limitations in clinical trials of VEGF.

1 January 2021 in Journal of Controlled Release
Verified
Journal Article
Closed access
Fabio Rocha FormigaFabio Rocha Formiga
Fabio Rocha Formiga
RLRoger Leblanc
Roger Leblanc
JRJuliana de Souza Rebouças
Juliana de Souza Rebouças
LFLeonardo Paiva Farias
Leonardo Paiva Farias
RORonaldo Nascimento de Oliveira
Ronaldo Nascimento de Oliveira
LPLindomar Pena
Lindomar Pena

1 January 2013 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
TSTeresa Simón-Yarza
Teresa Simón-Yarza
Fabio Rocha FormigaFabio Rocha Formiga
Fabio Rocha Formiga
ETEsther Tamayo
Esther Tamayo
BPBeatriz Pelacho
Beatriz Pelacho
FPFelipe Prosper
Felipe Prosper
María J. Blanco PrietoMaría J. Blanco Prieto
María J. Blanco Prieto

1 April 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ESEdmilson Clarindo de Siqueira
Edmilson Clarindo de Siqueira
JRJuliana de Souza Rebouças
Juliana de Souza Rebouças
IPIrapuan Oliveira Pinheiro
Irapuan Oliveira Pinheiro
Fabio Rocha FormigaFabio Rocha Formiga
Fabio Rocha Formiga